Stanniocalcin (STC) is a polypeptide hormone discovered first in fish and more recently in mammals. In mammals, the gene is widely expressed and the hormone is, so far, known to be involved in regulating the transport of calcium or phosphate across renal and gut epithelia, and into neuronal cells. Gene expression is also high during development, and in an earlier study we mapped the temporal and spatial pattern of gene expression in the mouse urogenital system. Our data suggested that STC probably acted as a signaling molecule that was produced in mesenchyme cells and targeted to epithelial cell layers in both kidney and testes. Here we have examined STC mRNA and protein distributions between developmental stages E10·5 and E18·5 in the axial and appendicular skeleton. In the axial skeleton, STC was transiently expressed in a rostral-caudal fashion during vertebral development; protein appeared to be made in intervertebral disc mesenchyme cells and targeted to vertebral hypertrophic and prehypertrophic chondrocytes. By stage E18·5, the STC gene was active only in vertebral perichondrocytes. The pattern of expression in the appendicular skeleton was equally striking. Early in development, STC gene expression defined the initial lengths of bone primordia. The gene was expressed in mesenchyme cells at either ends of precartilaginous condensations defining future long bones and the secreted protein was targeted to the chondroblasts. Later on during joint formation, STC was highly expressed in interzone cells that defined all future joints. After cavitation, STC gene expression was greatest in perichondrocytes lining the joints. Underlying resting, proliferative and prehypertrophic chondrocytes appeared to be the targets of STC both during and after cavitation. Therefore, its pattern of expression was indicative of a role in early skeletal patterning and joint formation. Moreover, as occurs during urogenital development, it appeared that STC is made in undifferentiated mesenchyme cells and sequestered by those destined to differentiate.
Introduction
Stanniocalcin (STC) is a 50 kDa disulfide-linked, homodimeric glycoprotein that was discovered first in fish and more recently in mammals. In mammals and fish the STC gene is widely expressed and in both groups the hormone plays a part in mineral homeostasis (Wagner 1994 , Wagner et al. 1986 , Chang et al. 1995 , Olsen et al. 1996 , McCudden et al. 2001 . In mammals, STC promotes the reabsorption of inorganic phosphate across renal and intestinal epithelia, and reduces intestinal calcium transport (Wagner et al. 1997 , Madsen et al. 1998 . STC also has a role in neuronal cell differentiation and, by increasing the rate of phosphate uptake, may protect neurons from ischemic insults (Zhang et al. 1998 (Zhang et al. , 2000 .
STC is also highly expressed during embryogenesis, which is indicative of it having some importance to development (Varghese et al. 1998) . This has prompted us and others to analyze in more detail the temporal and spatial patterns of expression of STC during development, using mouse as a model. The first of these studies traced the patterns of STC immunoreactivity (STCir) in axial skeletal development up to stage E14·5, and revealed high levels in cells of the chondrocyte lineage, particularly in intervertebral discs (Jiang et al. 2000) . We then examined mouse urogenital development between stages E10·5 and 18·5 and found intriguing patterns of gene expression in kidney and testes: in both organs the gene was expressed in mesenchymal cells, whereas the protein was much more evident in adjacent epithelial cells . Findings such as these were suggestive of local STC signaling between the two cell types. In a follow-up study we examined patterns of gene expression in the uterus after blastocyst implantation. Here we observed that STC was expressed uniquely in mesometrial stromal cells and targeted to/sequestered by decidualizing anti-mesometrial cells, indicative of a role in decidualization and uterine remodeling . Hence, these latter studies demonstrated the necessity of screening for both mRNA and protein to obtain some indication as to the source of the hormone and the direction in which it appeared to signal. The importance of STC to development has been further revealed through transgenesis, as the over-expression of human (h) STC in the mouse leads to significant reductions in birth weight, adult dwarfism and significant increases in serum phosphate concentrations . The present study attempted to build on this previous body of work by delineating the patterns of distribution of STC mRNA and protein during all relevant stages of axial and appendicular skeletal development (E10·5 to E18·5). The data suggests that, as in other tissues, STC signals locally between adjacent cell types and appears to be involved in both skeletal patterning and joint formation.
Materials and Methods

Tissue preparation
Standardized timed mating schemes were arranged between 6-week-old CD-1 mice. Embryos were isolated between days E10·5 and E18·5, fixed overnight at 4 C in 4% paraformaldehyde in PBS (pH7·5), dehydrated and embedded in paraffin, and sectioned at 6 µm for immunocytochemistry and in situ hybridization. Ten to 16 fetuses were evaluated per stage from multiple pregnancies.
Immunocytochemistry
The antiserum used was generated in rabbits against baculovirus-expressed recombinant hSTC and has been extensively characterized by immunocytochemistry (ICC), western blot analysis and radioimmunoassay for specificity in humans and rodents (Varghese et al. 1998 , Niu et al. 2000 . For ICC staining, slides were deparaffinized and rehydrated, and endogenous peroxidase activity was quenched by a 30 min treatment in 0·3% hydrogen peroxide in methanol. The staining procedure involved pretreatment of tissue sections with 10% normal goat serum in diluent buffer (PBS) to reduce non-specific staining, followed by an overnight incubation at 4 C with a 1:1000 dilution of the antiserum. Sites of antibody binding were then visualized with the vectastain avidinbiotin complex peroxidase detection system according to the manufacturer's instructions (Vector Labs, Burlingame, CA, USA). Slides were counterstained with Harris hematoxylin, dehydrated and mounted. Control procedures involved the application of antiserum preabsorbed with hSTC (1 mg/ml) in lieu of antiserum alone.
In situ hybridization
In situ hybridization (ISH) was carried out using a previously established procedure with an 815 bp cDNA encoding 247 amino acids of mouse STC for generating sense and antisense riboprobes (Varghese et al. 1998 , Wong et al. 1998 Canada) . Briefly, hydrated tissue sections were treated with proteinase K, post-fixed in 4% paraformaldehyde, acetylated, dried and then hybridized overnight at 50 C in a solution of 50% formamide, 0·4 M NaCl, 10 mM Tris HCl pH 8·0, 1 mM EDTA pH 8·0, 1 Denhardt's solution, 10% dextran sulfate, 20 mM dithiothreitol, 600 µg/ml denatured yeast transfer RNA, and 0·1 µg labeled RNA probe/ml solution. After extensive posthybridization washes, single-stranded riboprobe was digested with RNase A. Slides were finally dehydrated, air-dried, dipped in Kodak NBT2 nuclear track emulsion and then stored at 4 C in light-tight boxes containing silica gel as desiccant for 13-21 days. Slides were developed in Kodak D-19, counterstained with hematoxylin, dehydrated and mounted under coverslips. Digital images were captured using a SPOT camera (Diagnostic Instruments, Sterling Heights, MI, USA).
Results
STC mRNA and protein in axial skeleton
In axial skeleton, STC gene expression proceeded in a rostral-caudal direction, coincident with the progressive differentiation, segmentation and patterning of sclerotomal somites into components of the axial skeleton, beginning at developmental stage E10·5. By stage E11·5, gene expression became restricted to the rostral, less condensed halves of a dozen or more individual sclerotomal segments along the post-cranial axis (Fig. 1A) . Little or no signal was found in the caudal half, characterized by its greater cell density (Fig. 1B) . In contrast, STC protein was readily apparent in cells of both halves of the somite (Fig. 1C) .
With the successive differentiation of these sclerotomal components over developmental stages E12·5-E13·5 into vertebrae, ribs and intervertebral discs, an even more restricted pattern of STC gene expression was observed. The highest levels of STC mRNA were now in intervertebral disc anlagens as they developed in a rostral to caudal direction. A good example of this is illustrated in Fig. 1D and E, where the most intense hybridization was found in condensing lumbar-sacral intervertebral discs between the precartilage vertebral bodies. In contrast, gene expression was undetectable in the rostral, more developmentally advanced thoracic vertebrae and ribs, now defined by a perichondrium. Gene expression was also absent from the more caudal and less developmentally advanced coccygeal somites.
STC protein was found in stage-specific patterns of staining between stages E12·5 and E13·5. In the lumbar-sacral region, STC protein co-localized in areas of high gene expression in the condensing intervertebral discs (Fig. 1F ) and in primitive vertebrae also (Fig. 1F,G) . By stage E13·5, STC mRNA levels had decreased in the developmentally more advanced cervical-thoracic regions, yet they still contained high levels of STCir. This was particularly evident in the newly formed vertebral and rib perichondria, intervening fibrocartilage and select chondrocytes (Fig. 1D inset, arrowheads) . By stage E14·5, however, STC gene activity had moved caudally and was now greatest in the intercoccygeal discs, whereas all discs rostral to the tail had little if any STC mRNA (not shown). Intervertebral discs again contained the most STCir, although low levels were found in adjacent regions of lower cell density destined to become coccygeal vertebrae (not shown). STC protein was also now evident in the chondrocytes of future skeletal elements, once they had been defined by a perichondrium (not shown).
With the completion of tail somite differentiation at stage E15·5 and commencing maturation of cartilaginous elements, the entire axial skeleton now exhibited only low levels of STC expression in intervertebral disc mesenchyme cells. Instead, gene expression was now confined to the perichondrium of vertebral elements (Fig. 1H) . STC protein co-localized with mRNA in perichondrial cells and was also found in the chondrocytes of developing skeletal elements (Fig. 1I,J) . Figure 1J highlights the heterogeneous nature of STCir in differentiating chondrocytes: those containing high levels of STCir were more likely to have less compact chromatin, indicative of greater cellular activity. Over the remaining days of embryogenesis there was a marked reduction in STC synthesis, coinciding with further axial skeleton development.
Overall, our protein localization data in axial skeleton agreed with earlier findings (Jiang et al. 2000) . However, with the added gene expression data our findings further revealed that, early on, STC appears to be produced by one cell type and targeted to adjacent cells in condensing perichordal mesenchyme, possibly abetting in early segmentation/patterning events. Later on, however, STC is involved in intervertebral disc formation and chondrogenesis in skeletal elements. A diagrammatic summary of these events is shown in Fig. 2 .
STC in appendicular skeleton
Activation of STC gene transcription coincided with three major events in limb development: condensation, growth and segmentation. Low levels of STC mRNA and protein were first seen in E9·5 limb buds (data not shown). However by developmental stage E11·5, mRNA and protein were both clearly evident in cells bordering the proximal and distal regions of precartilaginous condensations within the limbs (Fig. 3A) . These rod-shaped digital primordia were visible in the hind limb under bright field illumination (Fig. 3B ). Low levels of STC mRNA were also found in mesenchyme cells surrounding the developing digital rays (Fig. 3A, arrowheads) . Most of the STCir was confined to mesenchyme cells immediately around the developing digits (Fig. 3C) . A similar pattern was seen in E12·5 fore limbs (data not shown).
By stage E13·5, in the developmentally more advanced fore limb (approximately half a day ahead of the hind limb) the highest levels of STC gene expression were now confined to the mesenchymal condensations at the most distal ends of the developing metacarpal elements (Fig. 3D ,E, arrowheads), coinciding with the development of the presumed metacarpal-phalangeal joint. A moderate level of gene expression was also found between more proximal carpal elements. In contrast, chondroblasts in these carpal and metacarpal elements were generally devoid of STC mRNA, but in some cases were positively stained for STC protein (Fig. 3F , arrows). Regions containing the highest levels of STC mRNA contained little or no protein (Fig. 3F, arrowhead) .
Subsequently, between developmental stages E14·5 and 18·5, STC gene expression became concentrated in all regions of joint formation (or future joint formation) in fore and hind limb digits, and in shoulder/elbow/wrist and hip/knee/ankle regions. In contrast, STC protein was evident in a large proportion of chondrocytes within the respective cartilage elements, and in some perichondrocytes. A good example of this is the E15·5 hind limb shown in Fig. 3G -I, where STC mRNA is present in almost all regions of bone apposition. Here, it can be seen that the greatest levels of expression were found in the interzones of metatarsal-phalangeal joints ( Fig. 3G -I, large red arrowheads) and to a lesser extent in more distal interphalangeal joint regions ( Fig. 3G -I, small red arrowhead). Moderate signal was also evident in cells lining the spaces between the various tarsal elements (e.g. cuneiformes, naviculare, cuboideum), but cells lining the talus-calcaneus joint had a particularly high level of expression (Fig. 3G, yellow arrowhead) . However, as noted above, Fig. 3J reveals that the pattern of STC protein staining was markedly different. Chondrocytes of the tarsal and digit cartilaginous elements contained the highest levels of STCir, whereas lower levels were seen in gene-expressing cells of the perichondrium and actual joints regions (Fig. 3J) . Skin was also highly immunoreactive for STC (Fig. 3J) . The pattern was similar in E16·5 hind limb, except for the fact that STC gene activity was now also evident in perichondrocytes extending back from the joint interzones on the lateral margins of cartilage elements (Fig. 3K, arrowheads) . Once again, however, most of the STCir was in chondrocytes, not the perichondrium. Figure 3L is a high magnification of the hind limb tarsal elements shown in Fig. 3K . Highlighted here are the high levels of STCir in chondrocytes that apparently do not produce STC (arrow), as compared with the weak STCir in cells of the interzone (iz) and perichondrium (arrowhead) that expressed the gene at high levels.
Other more proximal appendicular regions exhibiting strong gene expression at developmental stage E15·5 included the elbow and knee joints (Fig. 3M) , where the highest levels coincided with cavitation (arrows). After cavitation, STC gene expression became confined to the joint perichondrial surfaces (see Fig. 4C for an example of this). High levels of STC mRNA were also apparent in future articular surfaces of the humerous-scapula (or gleno-humeral) shoulder joint (Fig. 4A , and inset, arrowhead), whereas STC protein was evident in both perichondrocytes and chondrocytes of the underlying hyaline cartilage (Fig. 4B) .
By E18·5, STC gene expression was highest following cavitation of the most distal inter-phalangeal joints of the fore limb and STC mRNA was again restricted to the outermost layer of cells forming the opposing articular surfaces (Fig. 4C ,D, arrowheads and arrows). STC protein co-localized with the mRNA, but was also evident in the underlying chondrocytes and associated ligaments (Fig. 4E, arrows) . Similar finding were observed in the hind limbs, particularly along the edges of the naviculare skeletal element of the ankle (data not shown).
The distribution of STC mRNA and protein in the epiphyseal growth plate of an E17·5 femur is illustrated at low magnification in Fig. 4 , panels F-H. As in the case of smaller long bones, STC gene expression in the E17·5 femur was restricted to the thin layer of perichondrocytes defining the articular surfaces (Fig. 4 I-1, I -2, arrows). In contrast, high levels of STCir were also found in chondrocytes of the resting, proliferative and hypertrophic zones of the growth plate (Fig. 4 I-3 , J-M). Cells of the prehypertrophic and hypertrophic zones appeared to contain the least amount of STC protein (Fig. 4J, K) , whereas the highest levels of STCir were found in osteoblasts of newly forming trabecular bone (Fig. 4L) . In all of the above studies, the use of antiserum preabsorbed with hSTC (for ICC) and radiolabeled sense probes (for ISH) produced no specific staining or hybridization respectively (data not shown)
In summary, STC mRNA in appendicular skeleton was restricted to a discrete population of cells in regions before (regional mesenchymal condensation), undergoing (interzone) or completing (articular surface) joint formation. In contrast, the protein was most abundant in interdigital mesenchyme and chondrocytes. This clear-cut discrepancy between mRNA and protein is indicative of a signaling pathway whereby STC is made in interzone cells and perichondrocytes and targeted to and accumulates in chondrocytes in the process of differentiation.
Discussion
In an earlier study, we characterized the patterns of STC gene expression and protein distribution in developing mouse kidney and testis. In both organs, a mesenchyme-epithelial signaling pathway was evident, whereby STC was produced in mesenchyme cells and targeted to/sequestered by nearby epithelial cells ). The present study has now revealed equally distinctive patterns of STC mRNA and protein localization during skeletogenesis, coinciding with initial patterning and subsequent differentiation of the axial and appendicular skeletons. Furthermore, it appears that, as in the urogenital system, the gene is expressed for the most part in undifferentiated cells and targeted to cartilage cells in various stages of terminal differentiation. Because STCir was clearly evident in cells having no apparent gene activity, we are assuming, as we have in previous studies, that these cells are targets of STC and have sequestered the hormone . We are further assuming that the STC they contain is derived from nearby mesenchymal cells, perichondrocytes, or both. Nonetheless, without evidence to the contrary, we still cannot entirely rule out the alternative explanation that there are indeed low levels of STC mRNA in differentiating chondrocytes that escaped detection by our isotopic in situ technique.
STC in the axial skeleton
The pattern of STC gene expression in axial skeleton, as summarized in Fig. 2 , was most like that reported for the transforming growth factor 3 (TGF 3) gene. TGF 3 mRNA is found early in condensations of perichordal mesenchyme between vertebral bodies, then the discs, and later the perichondrium (Pelton et al. 1990 , Millan et al. 1991 , Schmid et al. 1991 . Other TGF 3 superfamily members with overlapping patterns of expression included activins and inhibins. Like STC, mRNAs encoding both A and B subunits are found in developing intervertebral discs, along with follistatin, an activin binding protein (Feijen et al. 1994) . The mouse XlHbox gene is also expressed in segmented mesoderm along the anterior-posterior axis and in intervertebral discs (Deutsch et al. 1988 , Oliver et al. 1988 , Wallin et al. 1994 . Pax1 is expressed in perichordal mesenchyme and later in discs, where it shows temporal and spatial similarities with STC, albeit spanning a longer period of time (Deutsch et al. 1988 , Wallin et al. 1994 . Interestingly, spontaneous Pax1 mutants almost always lack vertebral bodies and intervertebral discs (Wallin et al. 1994) .
The patterns of expression of STC mRNA and protein are indicative of a role for STC in axial patterning and growth of the intervertebral discs, vertebrae and ribs. The notion that STC regulates these events is also supported by recent data showing that the over-expression of STC in mice reduces growth, pre-and post-natally , the implication being that skeletal maturation has been accelerated by excess STC. This notion is also supported by a recent study showing that STC actively promotes bone nodule formation in rat fetal calvaria (Yoshiko et al. 2000) . The present findings and those published recently on the distribution of STCir in mouse axial skeleton (Jiang et al. 2000) suggest that these effects probably occurred in part through the chondrocytes, given the high levels of STCir found at different stages of chondrocyte differentiation. Parathyroid hormone-related protein (PTHrP) is just as widely distributed during embryogenesis and, interestingly, null mutants have profound defects in axial and appendicular skeleton as a result of accelerated endochondral mineralization. Because PTHrP is normally expressed in resting chondrocytes and targeted to slow the growth rate of prehypertrophic chondrocytes, the cells multiply and mineralize more rapidly in null mutants (Karaplis & Kronenberg 1996 , Lanske et al. 1996 , Vortkamp et al. 1996 . TGFs 1-3, which are also expressed in perichondrocytes (Heine et al. 1987 , Pelton et al. 1990 , also appear to act as negative regulators of chondrocyte differentiation, but upstream of PTHrP (Serra et al. 1999) . The data on STC collectively suggest that it, too, may function as a regulator of chondrogenesis.
STC in the appendicular skeleton
Over the early stages of appendicular skeletal development and before the onset of chondrogenesis, STC mRNA and protein co-localized in the general contours outlining future limbs (precartilaginous condensations) and were especially noticeable in more proximal areas where joint formation was about to take place. Its presence in such a spatially restricted manner, before overt cartilage development, is suggestive of a role in defining inceptive boundaries. Similarly, the distinctive patterns of expression of the gene in all joint interzone regions up to and including the time of cavitation, when it became confined to the articular surfaces, is equally suggestive of a role for STC in joint formation.
The patterns of STC gene expression and protein accumulation in appendicular skeletal joints, as summarized in Fig. 2 , are highly unique relative to what has previously been described in the developing skeleton. Various proteins are found in developing cartilage and nearby structures during joint formation, including tenacin-C, syndecan-3 (Koyama et al. 1995) , types I, II, and XI collagens, and keratan sulfate (Craig et al. 1987 , Axial: Segmentation in vertebrates occurs with the condensation of mesoderm to form somites; over developmental stages E11-E13 in mice, these differentiate into dermatome, myotome and sclerotome, generating dermal, muscle and skeletal tissue respectively. Of interest here is the sclerotomal component giving rise to the axial skeleton. The top panel is representative of the E11·5 cervical-thoracic region as seen in Fig 1A-C , where each sclerotome unit consists of a rostral zone of low cell density and a more dense caudal zone. Cells in the rostral zone produce STC and target it to cells in the caudal zone. The middle panel is representative of E14·5 axial skeleton after vertebral condensation. The gene is now expressed in the intervertebral disc primordium and targeted to precartilaginous cells within the vertebral bodies. Note that gene activity is restricted to the outermost layers of disc cells (as also seen in Fig. 1D,E) . The bottom panel is of E18·5 axial skeleton as in Fig. 1H ; by this time the gene is uniquely expressed in perichondrial cells lining the vertebral bodies, from whence it targets underlying vertebral chondrocytes. Appendicular: Limb development begins with the condensation of precartilaginous cells in the limb buds. The top right panel is representative of E13·5 limb where cells have begun condensing into skeletal elements as in Fig. 2A-C . STC production is restricted to mesenchyme cells defining the longitudinal boundaries of each element and targeted to the condensing cells. Middle panel: in preparation for joint formation, cells defining the new joint margins express the STC gene at high levels and target chondrocytes in adjacent skeletal elements, as in Fig. 2G -J, K-L. By stage E18·5 (bottom) and following joint cavitation, STC gene expression becomes restricted to perichondrocytes on articular surfaces and targeted to underlying chondrocytes, as in Fig. 4A -C and E. Nalin et al. 1995) , in addition to hyaluronan and hyaluronan binding proteins (Pitsillides et al. 1995 , Dowthwaite et al. 1998 ). However, surprisingly few genes have a pattern of expression comparable to that of STC in the developing joint itself. Moreover, although some genes are expressed in the joint region in a stage-specific manner (Gli3, Egr1, Bmp2, chordin), only growth and differentiation factor 5 (GDF5), shows significant overlap with STC mRNA at several stages of joint formation in mice. Like STC, GDF5 is expressed at high levels in the interzone regions of developing joints and around the periphery of long bones in the early stages of condensation. GDF5 has also been directly implicated in both joint formation and chondrogenesis, as GDF5 gene mutations are responsible for the skeletal abnormalities in brachypodism. In these mice, both long bone length and phalanx number are decreased, presumably as a result of regional failure to cleave the early condensations into two separate parts (Storm et al. 1994 , Storm & Kingsley 1996 . GDF5 mutations also cause various skeletal dysplasias in humans (Storm & Kingsley 1999) . The GDF5 receptor, Alk-6, is expressed in epiphyseal chondrocytes next to the joint (Dewulf et al. 1995 , Zoo et al. 1997 , Francis-West et al. 1999b ; as shown in the present study, these chondrocytes contain/sequester large amounts of STC protein at specific developmental stages. Also, like STC, the GDF5 gene is expressed in both synovial and fibrocartilaginous joints (Storm et al. 1994) . Therefore, given its similar distribution patterns, it is likely that STC is involved in early patterning, joint formation and chondrogenesis. In this regard, it is interesting to note that a recent review proposed the joint as a 'signaling center' from which numerous molecules signal in paracrine fashion to control skeletogenesis in the juxtaposed cartilage elements (Francis-West et al. 1999a) . In this context, STC appears to have the necessary characteristics of a 'signaling center' molecule.
Finally, it is interesting to note that, in bone, STC was produced in mesenchyme cells and sequestered by chondrocytes, much as in kidney and testis, where it is produced in mesenchyme and sequestered by epithelial cells ; the common denominator is that the protein is produced in less differentiated cells and targeted/sequestered by those undergoing active differentiation. This interpretation is, of course, based upon our aforementioned hypothesis that the cells containing only STC protein do not in fact express the gene. However, if the sequestering hypothesis proves to be true, then its significance in terms of development and cell signaling generally are questions that will need to be addressed. This is especially true in the case of tissues such as skin, that contain by far the highest levels of STCir but no evidence of gene activity. In this regard, one compartment that has not yet been mentioned and yet should be considered as a source of STC for cells with no apparent gene activity (chrondrocytes and keratinocytes) is maternal serum, which contains high levels of STCir during the latter half of gestation . It should also prove interesting to see if STC expression persists with the subsequent maturation and refinement of the articular cartilage joint surface in the postnatal period, and which, if any, patterns of expression are maintained throughout the adult life span. A recent report has revealed that STC mRNA is present in adult mouse chondrocytes and osteoblasts using digoxigenin-based in situ hybridization and northern blot analysis (Yoshiko et al. 1999) . Although relative levels of expression and putative targets were not investigated, these findings nonetheless imply that STC continues to be of importance to bone biology long after skeleton maturation. In support of these findings, we also observed high levels of STC protein in trabecular osteoblasts of the stage E17·5 femur. However, whereas we readily observed STC mRNA in articular perichondrocytes, we saw no evidence of gene activity in osteoblasts, using 35 S-labeled riboprobes. The discrepancy in our findings may simply reflect the different in situ techniques used (isotopic and non-isotopic in situ hybridizations). Therefore, if osteoblast-like cells do express the STC gene, it is probably in concentrations that are undetectable with 35 S-labeled riboprobes. In summary, therefore, STC was transiently expressed in a rostral-caudal fashion in intervertebral disc mesenchyme cells during vertebral development, and targeted to vertebral chondrocytes. The pattern of expression in appendicular skeleton was equally striking. Early on, STC gene expression defined the initial lengths of bone primordia and the gene product was targeted to precartilaginous condensations of mesenchyme cells. Later on, STC was highly expressed in interzone cells defining future joints and in perichondrocytes lining the joints after cavitation. Underlying resting, proliferating and hypertrophic chondrocytes appeared to be the targets of STC both during and after joint formation. Therefore, as in urogenital development, STC was made in undifferentiated mesenchyme cells and sequestered by differentiating cells. In this instance, however, the patterns of distribution of mRNA and protein were indicative of a role in early skeletal patterning and joint formation. It may be hoped that future studies will delineate both the interactions of STC with other bone morphogens and its precise roles in skeletal development.
